Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for

BenzingaJun 14 14:13 ET

Teva Pharmaceutical Sues Corcept Therapeutics, Down 8%, Alleging Market Monopolization for Cushing's Syndrome Drug Korlym

Teva Pharmaceutical Industries (TEVA) has sued Corcept Therapeutics (CORT), accusing the company of monopolizing the market for Korlym, a mifepristone-based drug used to treat Cushing's syndrome, acco

MT NewswiresJun 14 12:59 ET

Express News | Corcept Therapeutics Shares Are Trading Lower Following a Report Suggesting Teva Has Sued the Company, Accusing It of a Monopoly on Korlym

BenzingaJun 14 12:32 ET

Express News | Reported Late Thursday: Teva Sues Corcept Over Mifepristone 'Monopoly' For Rare Disorder

BenzingaJun 14 12:31 ET

Corcept Therapeutics (CORT) Is a Top-Ranked Momentum Stock: Should You Buy?

Yahoo FinanceJun 14 09:50 ET

Piper Sandler Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $35

Piper Sandler analyst David Amsellem maintains $Corcept Therapeutics(CORT.US)$ with a buy rating, and maintains the target price at $35.According to TipRanks data, the analyst has a success rate of 42

moomoo NewsJun 10 07:31 ET · Ratings